Celecoxib increases lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1

Ítems similars

• The role of human melanoma cell ICAM-1 expression on lymphokine activated killer cell-mediated lysis, and the effect of retinoic acid
  per: Alexander, C L, et al.
  Publicat: (1999)
• Lysis of primary hepatic tumours by lymphokine activated killer cells.
  per: Hsieh, K H, et al.
  Publicat: (1987)
• Lysis of allogeneic and autologous melanoma cells by IL-7-induced lymphokine-activated killer cells.
  per: Böhm, M., et al.
  Publicat: (1994)
• Induction but not inhibition of COX-2 confers human lung cancer cell apoptosis by celecoxib
  per: Ramer, Robert, et al.
  Publicat: (2013)
• Celecoxib upregulates ULBP-1 expression in lung cancer cells via the JNK/PI3K signaling pathway and increases susceptibility to natural killer cell cytotoxicity
  per: Kim, Jayoung, et al.
  Publicat: (2020)